|Adult ADHD Home||ADHD at Work||ADHD Self Test|
|Love & Friendships||Manage Time & Money||ADHD Adult Blogs|
|Organization Help||Stress, Sleep, Health||Adult Support Groups|
|Apps & Gadgets||Inspirational Stories||Expert Answers|
|ADHD Parenting Home||Schedules & Time||Sample Routines|
|Discipline & Behavior||Teens & Young Adults||Sleep & Nutrition|
|ADHD Parenting Skills||Nutrition & Diet||Parenting Blogs|
|Friendships & Social Skills||Sports & Hobbies||Summer & Camps|
|ADHD Treatment Home||ADHD Medications||Medication Reviews||Adderall|
|Treating Your Child||Nutrition & Diet||Fish Oil Printable||Daytrana|
|Expert Q&As||Non-Medical Treatment||Find Professionals||Strattera|
|Behavior Therapy||Brain Training||Quillivant XR||Vyvanse|
|ADHD/LD School Home||IEP/504 Plan||Get Organized!|
|Summer Learning||Accommodations||For Teachers|
|Back to School||The 3 Rs||School Behavior|
|Homework Help||Is It LD?||High School & College|
|ADHD Diagnosis Home||ADHD & Women||Is it ADHD? Self Tests|
|Getting a Diagnosis||Is it a Related Condition?||Medical Q&As|
|ADHD Symptoms||Post Diagnosis Next Steps||Myths & Realities|
|Is it Learning Disabilities?||ADHD Treatment||ADHD Support Groups|
|Tools and Checklists|
|ADHD Topics A-Z|
|Share Your Story|
|Give a Gift|
|Buy Back Issues|
Trials of New 16 Hour Medication Successful
Shire, the makers of Adderall, Vyvanse, and Daytrana, announced that trials of a new investigational drug improved ADHD symptoms for up to 16 hours.
Monday January 28th - 2:56pm
Filed Under: ADHD Stimulant Medications
After submitting a New Drug Application to the FDA in July, Shire Pharmaceuticals has recently announced the results of Phase II trials of the investigational medication-an amphetamine compound that could require only a once daily dose to control symptoms for up to 16 hours.
In two separate trials, participants taking the medication had significantly higher scores on tests of attention and ability to stay on tasks than did those taking a placebo. These results remained significant even at 16 hours after drug administration.
While the investigational drug did have some side effects, such as insomnia, decreased appetite, and headaches, these were not different from the side effects of other ADHD medications currently available.
The FDA is currently reviewing the New Drug Application for this medication.